Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujio Hayashi

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trialTakenori Domei, Ko Yamamoto, Masahiro Natsuaki, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary InterventionKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions|March 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total CohortHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
Cardiovascular Intervention and Therapeutics|February 18, 2014
Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudyMasao Imai, Takeshi Kimura, Takeshi Morimoto, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trialTakenori Domei, Ko Yamamoto, Masahiro Natsuaki, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary InterventionKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions|March 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total CohortHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
Cardiovascular Intervention and Therapeutics|February 18, 2014
Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudyMasao Imai, Takeshi Kimura, Takeshi Morimoto, et al.
Pageof 3